Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Cash and Short Term Investments (Quarterly): 605.54M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 605.54M |
| June 30, 2023 | 571.99M |
| March 31, 2023 | 201.25M |
| December 31, 2022 | 275.14M |
| September 30, 2022 | 309.51M |
| June 30, 2022 | 373.87M |
| March 31, 2022 | 437.66M |
| December 31, 2021 | 478.75M |
| September 30, 2021 | 245.76M |
| June 30, 2021 | 239.54M |
| March 31, 2021 | 283.12M |
| December 31, 2020 | 293.86M |
| September 30, 2020 | 188.22M |
| June 30, 2020 | 219.51M |
| March 31, 2020 | 247.30M |
| December 31, 2019 | 176.22M |
| September 30, 2019 | 204.49M |
| June 30, 2019 | 239.82M |
| March 31, 2019 | 270.40M |
| December 31, 2018 | 262.25M |
| September 30, 2018 | 303.20M |
| June 30, 2018 | 345.06M |
| March 31, 2018 | 218.38M |
| December 31, 2017 | 267.11M |
| September 30, 2017 | 194.85M |
| Date | Value |
|---|---|
| June 30, 2017 | 150.34M |
| March 31, 2017 | 126.57M |
| September 30, 2016 | 196.00M |
| June 30, 2016 | 245.03M |
| March 31, 2016 | 182.91M |
| December 31, 2015 | 212.28M |
| September 30, 2015 | 247.84M |
| June 30, 2015 | 278.11M |
| March 31, 2015 | 111.83M |
| December 31, 2014 | 106.60M |
| September 30, 2014 | 121.80M |
| June 30, 2014 | 142.26M |
| March 31, 2014 | 164.08M |
| December 31, 2013 | 178.09M |
| September 30, 2013 | 174.84M |
| June 30, 2013 | 194.96M |
| March 31, 2013 | 206.10M |
| December 31, 2012 | 211.02M |
| September 30, 2012 | 233.61M |
| June 30, 2012 | 160.94M |
| March 31, 2012 | 175.26M |
| December 31, 2011 | 168.37M |
| September 30, 2011 | 179.76M |
| June 30, 2011 | 191.21M |
| March 31, 2011 | 115.81M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
176.22M
Minimum
Dec 2019
605.54M
Maximum
Sep 2023
310.64M
Average
261.22M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| AbbVie Inc | 18.07B |
| Pfizer Inc | 12.69B |
| Johnson & Johnson | 26.22B |
| Merck & Co Inc | 7.093B |
| Cerevel Therapeutics Holdings Inc | 990.96M |